New cancer clinical trial: Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer

Published on: June 28, 2018 at 12:00PM
Conditions:   Prostate Cancer;   Endometrial Cancer
Interventions:   Drug: Rucaparib;   Drug: Nivolumab
Sponsors:   University of Chicago;   Bristol-Myers Squibb;   Clovis Oncology
Not yet recruiting
https://ift.tt/2N8lOat